Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Luz Saude owner seeks over $330 million in Lisbon IPO - sources

Published 02/06/2023, 15:52
Updated 02/06/2023, 15:55
© Reuters.
C
-

By Pablo Mayo Cerqueiro and Sergio Goncalves

LONDON/LISBON (Reuters) - Fidelidade is set to raise at least 300 million euros ($330 million) by selling a minority stake in its healthcare arm Luz Saude, two people familiar with the matter said, in what could be Portugal's biggest initial public offering (IPO) in a decade.

The insurer, backed by China's Fosun International, is pondering whether to sell any new shares as part of the offering to help expedite Luz Saude's growth, said the people, who requested anonymity as deliberations are private.

It aims to launch the IPO this year or in the first half of 2024, depending on market conditions, with Euronext Lisbon as the preferred listing venue, the people said.

A deal would help to heal Europe's bruised IPO market, although rising interest rates and economic uncertainty make the path to a listing uncertain. No final decisions have been made, and plans could yet be altered or dropped, the people added.

Fidelidade declined to comment. Luz Saude and Fosun did not respond to a request for comment.

Reuters first reported last month that Fidelidade was sounding out banks to manage a stock market listing of Luz Saude that could value the company around 1 billion euros, despite sluggish IPO markets.

The insurance group has since appointed Citigroup (NYSE:C) and UBS as global coordinators and Portugal's Caixa Banco de Investimento as joint bookrunner, the people said.

It is in advanced discussions to draft local lender Millennium BCP and Germany's Hauck Aufhäuser Lampe - both also backed by Fosun - as co-lead managers, they said, adding further banks may still join the syndicate.

U.S. corporate finance house Evercore is Fidelidade's financial adviser, one of the people added.

Evercore and UBS declined to comment. The remaining banks did not respond to a request for comment.

For Portugal, whose main bourse has not seen any new listings since 2021, a return of Luz Saude to the stock exchange would be a major win, making it the biggest domestic flotation since Correios de Portugal in 2013.

Local lender Novo Banco, backed by investment manager Lone Star, has also voiced an ambition to go public in the medium term.

($1 = 0.9084 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.